Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 2

NCT05945823

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

This is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 study to evaluate the efficacy, safety, and tolerability of futibatinib in combination wi…

United States53 participantsStarted 2023-07-13

Treatment: Futibatinib, Pembrolizumab